Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

BRKR – Bruker Corporation

BRKR — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

11.6

Margin Of Safety %

-28

Put/Call OI Ratio

0.75

EPS Next Q Diff

0.24

EPS Last/This Y

2.27

EPS This/Next Y

0.29

Price

44.72

Target Price

49.15

Analyst Recom

1.93

Performance Q

7.58

Upside

-111.8%

Beta

1.15

Ticker: BRKR




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-13BRKR39.040.790.165810
2026-04-14BRKR39.890.730.666150
2026-04-15BRKR39.50.731.626194
2026-04-17BRKR40.690.760.546301
2026-04-20BRKR41.10.900.145188
2026-04-21BRKR40.10.800.755605
2026-04-23BRKR36.240.791.146544
2026-04-24BRKR36.540.811.006712
2026-04-27BRKR36.520.820.196758
2026-04-28BRKR36.280.822.726784
2026-04-29BRKR34.30.831.846852
2026-04-30BRKR36.690.852.256934
2026-05-01BRKR36.790.850.506988
2026-05-04BRKR36.380.831.357049
2026-05-05BRKR38.020.830.767083
2026-05-06BRKR42.290.800.787251
2026-05-07BRKR43.750.810.217519
2026-05-08BRKR44.170.808.867596
2026-05-11BRKR43.280.750.577405
2026-05-12BRKR44.720.750.347426
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-13BRKR39.04-51.0400.42.12
2026-04-14BRKR39.90-51.0408.72.12
2026-04-15BRKR39.49-51.0404.72.12
2026-04-16BRKR38.93-51.0399.42.12
2026-04-17BRKR40.70-51.1416.32.12
2026-04-20BRKR41.10-51.1420.12.12
2026-04-21BRKR40.10-51.1410.52.12
2026-04-22BRKR39.68-51.1406.52.12
2026-04-23BRKR36.24-51.1373.62.12
2026-04-24BRKR36.54-51.1376.52.12
2026-04-27BRKR36.52-51.1376.32.12
2026-04-28BRKR36.28-51.1374.02.12
2026-04-30BRKR36.72-51.1378.22.12
2026-05-01BRKR36.78-51.1378.92.12
2026-05-04BRKR36.38-51.1375.02.12
2026-05-05BRKR38.03-51.1390.82.12
2026-05-06BRKR42.27-51.1413.72.12
2026-05-07BRKR43.7443.2445.42.12
2026-05-08BRKR44.1643.2436.42.12
2026-05-11BRKR43.2924.3- 2.12
2026-05-12BRKR44.7220.5- 2.12
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-13BRKR-0.122.3512.19
2026-04-14BRKR-0.122.3512.19
2026-04-15BRKR-0.122.3512.19
2026-04-16BRKR-0.122.3512.19
2026-04-17BRKR-0.122.3512.19
2026-04-20BRKR-0.122.4112.19
2026-04-21BRKR-0.122.4112.19
2026-04-22BRKR-0.122.4112.19
2026-04-23BRKR-0.122.4112.19
2026-04-24BRKR-0.122.4112.19
2026-04-27BRKR-0.122.4012.38
2026-04-28BRKR-0.122.4012.38
2026-04-29BRKR-0.122.4012.38
2026-04-30BRKR-0.122.4012.36
2026-05-01BRKR-0.122.4012.36
2026-05-04BRKR-0.122.7312.36
2026-05-05BRKR-0.122.7312.36
2026-05-06BRKR-0.122.7312.36
2026-05-07BRKR-0.122.7311.50
2026-05-08BRKR-0.142.7311.50
2026-05-11BRKR-0.134.1111.50
2026-05-12BRKR-0.134.1111.60
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

0.31

Avg. EPS Est. Current Quarter

0.39

Avg. EPS Est. Next Quarter

0.55

Insider Transactions

-0.13

Institutional Transactions

4.11

Beta

1.15

Average Sales Estimate Current Quarter

854

Average Sales Estimate Next Quarter

896

Fair Value

32.2

Quality Score

54

Growth Score

59

Sentiment Score

93

Actual DrawDown %

52.9

Max Drawdown 5-Year %

-68.7

Target Price

49.15

P/E

Forward P/E

18.5

PEG

1.24

P/S

1.97

P/B

2.78

P/Free Cash Flow

132.73

EPS

-0.24

Average EPS Est. Cur. Y​

2.12

EPS Next Y. (Est.)

2.41

Target Price Estimates Raised

4

Target Price Estimates Lowered

Profit Margin

-1.05

Relative Volume

0.86

Return on Equity vs Sector %

-28.3

Return on Equity vs Industry %

-13.3

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

BRKR Healthcare
$44.73
📉
Swing / Pullback
Buy the dip on strong trends
39 /100
WEAK
Trend
14/20
Pullback
6/25
Volume
4/15
Valuation
9/20
TP/AR
2/10
Options
4/10
RSI
68
Range 1M
98.2%
Sup Dist
4.9%
🚀
Momentum Growth
Ride accelerating trends
46 /100
WEAK
Momentum
13/25
Growth
15/30
Estimates
4/20
Inst/Vol
6/15
Options
8/10
EPS Yr
15.8%
EPS NY
14.1%
52W%
58.5%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟡 HOLD +2.8% upside
Quality
5/30
Valuation
5/30
Growth
12/25
Stability
7/10
LT Trend
4/5
Upside
+2.8%
Quality
54
MoS
-28%
Bruker Corporation
Sector: Healthcare
Industry: Medical Devices
Employees: 11085
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
BRKR

Latest News

Caricamento notizie per BRKR
stock quote shares BRKR – Bruker Corporation Stock Price stock today
news today BRKR – Bruker Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch BRKR – Bruker Corporation yahoo finance google finance
stock history BRKR – Bruker Corporation invest stock market
stock prices BRKR premarket after hours
ticker BRKR fair value insiders trading